Is Pfizer’s 6.5% Dividend a Yield Trap? Q1 Results Put Speculation to Rest

Life Science

Net Income Soars 66%! CVS Health’s Q1 Results Shatter Slow-Growth Narrative

Financial Service, Life Science

Quarterly Sales Reach $8.7 Billion, Eli Lilly’s Mounjaro Becomes New Blockbuster Drug King

Life Science

Three Under-the-Radar Biotech Stocks to Watch in 2026

Life Science

UnitedHealth Soars 36.9% in April, As Earnings Beat Unlocks Valuation Recovery Runway

Financial Service, Life Science

Stop Chasing Overvalued Tech: These 2 Underrated Growth Stocks Are Too Cheap To Ignore

Life Science, Technology

Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint

Life Science

Stock Isn’t Cheap but Still Worth Buying? Three Hard Reasons Behind Eli Lilly Explained

Life Science

Dark Horse in the Weight-Loss Drug Arena? Viking Therapeutics Has Potential Upside of Over 200%

Life Science

GLP-1s and AI Are the Big Themes Behind These 5 Top-Rated Health Care Picks for 2026

Life Science

Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering

Life Science

Bristol Myers Squibb Beats on Q1 Sales, Profit; Stock Jumps 5% as Growth Portfolio Shines

Life Science

How to Invest a $1,000 Tax Refund? Two TSX Stocks Worth Watching

Life Science, Technology

Shorted-to-The-Hilt KalVista Rockets 39% as Chiesi Swoops in With $1.9bn Cash Bid

Life Science

Biogen’s Q1 Net Profit Rises 19%, Driven by Growth Products

Life Science